<journal article>
Clinical Results of Preoperative CDDP/5-FU Chemotherapy Followed by Surgery for Patients with Clinical Stage II/III Thoracic Esophageal Cancer

Creator
Language
Publisher
Date
Source Title
Vol
Issue
First Page
Last Page
Publication Type
Access Rights
JaLC DOI
Related DOI
Related URI
Related HDL
Abstract Purpose : The purpose of this study was to clarify the outcomes of preoperative CDDP/5-FU chemotherapy (FP therapy) followed by surgery for patients with clinical Stage II/III thoracic esophageal canc...er. Methods : Seventeen patients with clinical Stage II/III thoracic esophageal cancer who underwent FP therapy followed by esophagectomy were investigated with regard to the perioperative clinical results and postoperative outcomes. Results : Grade 3 or 4 adverse effects associated with FP therapy were recognized in 2 of the 17 (11.8%) cases, and 16 patients completed 2 cycles of FP therapy (94.1%). Complications after surgery occurred in 7 cases (41.2%). There were 7 patients with postoperative recurrences (41.2%), 6 of whom had clinical Stage III disease. Similarly, 4 out of the 5 patients who died of cancer had clinical Stage III disease. All recurrences and cancer-related deaths were recognized in histological effectiveness of Grade 0/1 cases. Conclusions : Preoperative FP therapy was found to be safe for patients with clinical Stage II/III thoracic esophageal cancer. However, the treatment seemed to be less beneficial for Stage III patients than for Stage II patients, thus suggesting that a more powerful preoperative treatment may be necessary for clinical Stage III patients.
【目的】CDDP/5-FU(FP療法)を用いた術前化学療法(NAC)後,手術を施行したcStageII/III胸部食道癌症例の転帰について明らかにすることである.【方法】当科でFP療法後に食道切除術が施行された胸部食道癌症例17例の周術期治療成績および術後転帰について調査した.【結果】Grade3/4のNAC関連副作用を2例(11.8%)に認めたが,16例(94.1%)で2サイクルのNACを完遂出来た.術後合併症は7例(41.2%)に認めた.術後7例(41.2%)に再発を認め,その内6例がcStageIIIであり,5例認めた癌死の内4例がcStageIIIであった.また,すべての再発・癌死例は,術後病理所見による治療効果判定がGrade0/1症例であった.【考察】FP療法は安全な治療法であるが,その効果はcStageII症例に比べcStageIII症例では弱いように思われ,cStageIII症例はより強力な術前治療が必要と考えられた.
show more

Hide fulltext details.

pdf p523 pdf 1.13 MB 429  

Details

PISSN
NCID
Record ID
Peer-Reviewed
Related PubMed ID
Subject Terms
Type
Created Date 2014.04.21
Modified Date 2021.07.28

People who viewed this item also viewed